Ipamorelin / CJC-1295
Growth-Hormone Secretagogue Research Peptide Pair
Overview
Ipamorelin and CJC-1295 are two synthetic research peptides frequently studied together in laboratory settings. Ipamorelin is a pentapeptide studied as a selective ghrelin-receptor research ligand, while CJC-1295 is a synthetic analog studied as a growth-hormone-releasing-hormone (GHRH) research ligand. Both are manufactured for laboratory research use only.
Mechanism of Action (Research Context)
Research has investigated Ipamorelin's activity at the ghrelin receptor and CJC-1295's activity at GHRH receptors, both studied for their roles in growth-hormone-axis signaling pathways. Published Ipamorelin research to date is primarily preclinical (animal and in-vitro pharmacology). CJC-1295 has additionally been evaluated in published early-phase human pharmacokinetic trials (cited below). Regardless of what has been published about either molecule elsewhere, the material Cinder Labs supplies is sold strictly for in-vitro and laboratory research use and is not intended for human or veterinary administration in any form.
Published Research
The studies below are real, publicly available research on Ipamorelin and CJC-1295, linked here for further reading and education. They are cited for research-context reference only — Cinder Labs does not endorse, guarantee, or make any therapeutic claim based on their findings, and does not sell these compounds for human or veterinary use.
Selective Growth Hormone Secretagogue (Ipamorelin)
"Ipamorelin, the first selective growth hormone secretagogue" — PubMed
Pharmacological characterization study describing Ipamorelin as a selective growth-hormone secretagogue and ghrelin-receptor ligand.
Prolonged GH/IGF-1 Stimulation in Healthy Adults (CJC-1295)
Human pharmacokinetic trial in healthy adult volunteers evaluating CJC-1295's effect on GH and IGF-I secretion.
Sustained GH Pulsatility (CJC-1295, Animal Model)
Research examining how CJC-1295's long-acting GHRH-analog activity affects GH pulsatility.
Storage & Handling
Store lyophilized peptide in a freezer (-20°C or below) prior to reconstitution. Once reconstituted for laboratory use, store refrigerated (2–8°C) and use within the timeframe recommended by your laboratory's standard operating procedures. Avoid repeated freeze-thaw cycles. Handle only in a controlled laboratory environment using appropriate personal protective equipment.